Centessa Pharmaceuticals plc (CNTA)
NASDAQ·Healthcare·Biotechnology
$40.50
—
Mkt Cap $3.51B
Analyst Ratings
No recent rating data.
Price Target (17 analysts)
$42.00
Range $42.00 – $42.00
Implied Upside
+3.7%
Consensus $42.00 vs current $40.50
NASDAQ·Healthcare·Biotechnology
$40.50
—
Mkt Cap $3.51B
No recent rating data.
Price Target (17 analysts)
$42.00
Range $42.00 – $42.00
+3.7%
Consensus $42.00 vs current $40.50